InvestorsHub Logo
Followers 2262
Posts 104413
Boards Moderated 3
Alias Born 12/17/2011

Re: None

Wednesday, 03/12/2025 8:40:32 AM

Wednesday, March 12, 2025 8:40:32 AM

Post# of 21
HMTXF...089...🥳...OTC partnering with a NAZ company sounds promising to me...Calgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated 498 patients for various forms of cardiovascular disease, including vascular dementia, announces its collaboration with Firefly Neuroscience, Inc. (NASDAQ: AIFF) ("Firefly"), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders.

Hemostemix and Firefly will study brain wave activity in up to 100 patients before and after treatment with ACP-01 at baseline, 3-months, and 6-months post-treatment (the "Phase 1").

https://www.otcmarkets.com/stock/HMTXF/news/Hemostemix-and-FireFly-Neurosciences-Brain-Network-Analytics-BNATM-Engage-to-Complete-Phase-1-Vascular-Dementia-Clinical?id=469780
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HMTXF News